1. Home
  2. BC vs SRRK Comparison

BC vs SRRK Comparison

Compare BC & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brunswick Corporation

BC

Brunswick Corporation

HOLD

Current Price

$79.12

Market Cap

5.7B

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$46.49

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BC
SRRK
Founded
1845
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.6B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BC
SRRK
Price
$79.12
$46.49
Analyst Decision
Buy
Strong Buy
Analyst Count
12
13
Target Price
$77.67
$56.17
AVG Volume (30 Days)
766.7K
1.6M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
2.20%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.81
N/A
Revenue Next Year
$5.11
$534.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.40
$27.07
52 Week High
$90.25
$51.63

Technical Indicators

Market Signals
Indicator
BC
SRRK
Relative Strength Index (RSI) 54.94 46.05
Support Level $78.15 $45.59
Resistance Level $89.67 $47.96
Average True Range (ATR) 2.88 1.71
MACD 0.49 -0.42
Stochastic Oscillator 57.69 4.25

Price Performance

Historical Comparison
BC
SRRK

About BC Brunswick Corporation

Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns 442 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: